Rare Causes and Differential Diagnosis in Patients With Silver‐Russell Syndrome

Barbara Leitao Braga,Renata da Cunha Scalco,Thais Kataoka Homma,Bruna Lucheze Freire,Laurana De Polli Cellin,Ana Pinheiro Machado Canton,Antônio Marcondes Lerario,Mariana Ferreira de Assis Funari,Vinicius de Souza,Debora Romeo Bertola,Alexsandra Christianne Malaquias,Berenice Bilharinho Mendonca,Alexander Augusto de Lima Jorge
DOI: https://doi.org/10.1111/cge.14659
2024-11-28
Clinical Genetics
Abstract:This study describes the molecular investigation of 39 children with clinical suspicion of Silver‐Russell syndrome at a tertiary center specialized in growth disorders. The results included differential diagnoses for 8 patients and underscore the importance of establishing a molecular diagnosis in this context to enable adequate management and genetic counseling. Silver‐Russell syndrome (SRS) is an imprinting disorder mainly characterized by pre‐ and postnatal growth restriction. Most SRS cases are due to 11p15.5 loss of methylation (11p15.5 LOM) or maternal uniparental disomy of chromosome 7 [UPD(7)mat], but several patients remain molecularly undiagnosed. This study describes the molecular investigation of children with a clinical diagnosis or suspicion of SRS at a tertiary center specialized in growth disorders. Thirty‐nine patients were evaluated with multiplex ligation‐dependent probe amplification, chromosomal microarray and/or massively parallel sequencing. The most common result was 11p15.5 LOM (n = 17; 43.5%), followed by UPD(7)mat (n = 2; 5.1%). Additionally, we found maternal duplications of the imprinting centers in 11p15.5 (n = 2; 5.1%), and genetic defects in SRS‐causing genes (IGF2 and HMGA2) (n = 3; 7.7%; two mutations and one deletion). Alternative molecular diagnoses included UPD(14)mat (n = 1; 2,6%), UPD(20)mat (n = 1;2,6%), copy number variants (n = 2; 5.1%), and mutations in genes associated with other growth disorders (n = 4; 10.3%), leading to diagnoses of Temple syndrome, Mulchandani‐Bhoj‐Conlin syndrome, IGF‐1 resistance (IGF1R), Bloom syndrome (BLM), Gabriele‐De Vries syndrome (YY1), Intellectual developmental disorder autosomal dominant 50 with behavioral abnormalities (NAA15), and Intellectual developmental disorder 64 (ZNF292). These findings underscore the importance of establishing the molecular diagnosis of SRS and its differential diagnoses to guide appropriate management and genetic counseling.
genetics & heredity
What problem does this paper attempt to address?